Trogenix (private company)
See something wrong or missing? Let us know
Offices:Edinburgh
Business model:B2B
Trogenix is a British biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour - via the Odysseus platform, which harnesses Synthetic Super-Enhancers (SSEs) to distinguish cancer cell states from healthy ones and drive selective payload delivery.
Investors:
we tracked 10 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 112.83M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Trogenix
Name | Criteria | |
---|---|---|
![]() |
Ability Pharma
70%
|
|
![]() |
AbolerIS Pharma
70%
|
|
![]() |
Acesion Pharma
70%
|
|
![]() |
Aignostics
70%
|
|
![]() |
Atai Life Sciences
70%
|
|
![]() |
Beckley Psytech
70%
|
|
![]() |
Bigfinite
70%
|
|
![]() |
CatalYm
70%
|
|
![]() |
Citryll
70%
|
|
![]() |
Inbrain Neuroelectronics
70%
|
|